CH469022A - Verfahren zur Herstellung von Derivaten des Cephalosporin C - Google Patents
Verfahren zur Herstellung von Derivaten des Cephalosporin CInfo
- Publication number
- CH469022A CH469022A CH916964A CH916964A CH469022A CH 469022 A CH469022 A CH 469022A CH 916964 A CH916964 A CH 916964A CH 916964 A CH916964 A CH 916964A CH 469022 A CH469022 A CH 469022A
- Authority
- CH
- Switzerland
- Prior art keywords
- cephalosporin
- derivatives
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB27989/63A GB1101423A (en) | 1963-07-15 | 1963-07-15 | Derivatives of 7-aminocephalosporanic acid |
| GB27990/63A GB1101424A (en) | 1963-07-15 | 1963-07-15 | Derivatives of 7-aminocephalosporanic acid |
| GB1474864 | 1964-04-09 | ||
| GB1474764 | 1964-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH469022A true CH469022A (de) | 1969-02-28 |
Family
ID=27448261
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH916964A CH469022A (de) | 1963-07-15 | 1964-07-13 | Verfahren zur Herstellung von Derivaten des Cephalosporin C |
| CH916864A CH469739A (de) | 1963-07-15 | 1964-07-13 | Verfahren zur Herstellung von Cephalosporinderivaten |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH916864A CH469739A (de) | 1963-07-15 | 1964-07-13 | Verfahren zur Herstellung von Cephalosporinderivaten |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US3243435A (de) |
| BE (2) | BE650445A (de) |
| BR (1) | BR6460800D0 (de) |
| CH (2) | CH469022A (de) |
| CS (1) | CS166185B2 (de) |
| DE (1) | DE1445835B2 (de) |
| DK (2) | DK124334B (de) |
| FR (2) | FR1455030A (de) |
| GB (2) | GB1101423A (de) |
| IL (2) | IL21639A (de) |
| NL (3) | NL6408066A (de) |
| NO (1) | NO128157B (de) |
| SE (1) | SE335532B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3365449A (en) * | 1964-07-23 | 1968-01-23 | Fujisawa Pharmaceutical Co | 7-(substituted thioacylamino) cephalosporanic acid and derivatives thereof |
| US3360515A (en) * | 1964-07-24 | 1967-12-26 | Fujisawa Pharmaceutical Co | 7-(condensed n-containing heterocyclic carbonamido) cephalosporanic acid and derivatives thereof |
| US3479350A (en) * | 1966-12-05 | 1969-11-18 | Glaxo Lab Ltd | Process for the manufacture of derivatives of cephalosporin c |
| GB1277415A (en) * | 1968-06-14 | 1972-06-14 | Glaxo Lab Ltd | Improvements in or relating to cephalosporin derivatives |
| US3687948A (en) * | 1970-11-23 | 1972-08-29 | Bristol Myers Co | 7-{8 D-(a-AMINO-a-PHENYLACETAMIDO){9 -3-(4-METHYL-1,3-OXAZOL-2-YLTHIOMETHYL-3-CEPHEM-4-CARBOXYLIC ACID AND SALTS THEREOF |
| US4024135A (en) * | 1976-03-05 | 1977-05-17 | E. R. Squibb & Sons, Inc. | (Carbamoyl)pyridino derivatives of ureidocephalosporins |
| GB1565941A (en) * | 1977-02-08 | 1980-04-23 | Toyama Chemical Co Ltd | Process for producing 7-(substituted)amino-3-substituted thiomethyl cephem carboxylic acids |
| JPS6027677B2 (ja) * | 1978-07-06 | 1985-06-29 | 富山化学工業株式会社 | ７−置換又は非置換アミノ−３−置換チオメチルセフエムカルボン酸類の新規製造法 |
| US4288590A (en) * | 1980-02-14 | 1981-09-08 | Bristol-Myers Company | 7-[Dα-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-arylacetamido]-3-(N,N-dimethyl-aminomethylpyridinium) methyl-3-cephem-4-carboxylates |
| ATE31535T1 (de) * | 1981-07-17 | 1988-01-15 | Glaxo Group Ltd | Cephalosporinverbindungen. |
| CA2935651A1 (en) | 2007-10-09 | 2009-04-16 | Gladius Pharmaceuticals Corporation | Broad spectrum beta-lactamase inhibitors |
| EP2539348A4 (de) * | 2010-02-26 | 2013-07-24 | Gary Igor Dmitrienko | Cephalosporinderivate als beta-lactamase-hemmer sowie zusammensetzungen damit und verfahren zu ihrer anwendung |
-
0
- NL NL130098D patent/NL130098C/xx active
-
1963
- 1963-07-15 GB GB27989/63A patent/GB1101423A/en not_active Expired
- 1963-07-15 GB GB27990/63A patent/GB1101424A/en not_active Expired
-
1964
- 1964-06-24 NO NO00153787A patent/NO128157B/no unknown
- 1964-07-02 IL IL21639A patent/IL21639A/xx unknown
- 1964-07-02 IL IL6421640A patent/IL21640A/xx unknown
- 1964-07-08 FR FR981074A patent/FR1455030A/fr not_active Expired
- 1964-07-09 US US381544A patent/US3243435A/en not_active Expired - Lifetime
- 1964-07-09 US US381580A patent/US3261832A/en not_active Expired - Lifetime
- 1964-07-10 BE BE650445D patent/BE650445A/xx unknown
- 1964-07-10 DK DK346364AA patent/DK124334B/da unknown
- 1964-07-10 DK DK346464AA patent/DK120544C/da active
- 1964-07-10 BE BE650444D patent/BE650444A/xx unknown
- 1964-07-10 BR BR160800/64A patent/BR6460800D0/pt unknown
- 1964-07-13 CH CH916964A patent/CH469022A/de unknown
- 1964-07-13 CH CH916864A patent/CH469739A/de unknown
- 1964-07-14 DE DE1964G0041087 patent/DE1445835B2/de active Granted
- 1964-07-15 CS CS4101A patent/CS166185B2/cs unknown
- 1964-07-15 NL NL6408066A patent/NL6408066A/xx unknown
- 1964-07-15 NL NL6408067A patent/NL6408067A/xx unknown
- 1964-07-15 SE SE08642/64A patent/SE335532B/xx unknown
- 1964-10-06 FR FR990461A patent/FR4315M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1101424A (en) | 1968-01-31 |
| US3261832A (en) | 1966-07-19 |
| GB1101423A (en) | 1968-01-31 |
| FR4315M (de) | 1966-08-01 |
| NO128157B (de) | 1973-10-08 |
| BR6460800D0 (pt) | 1973-08-02 |
| NL130098C (de) | |
| IL21640A (en) | 1968-04-25 |
| DE1445835A1 (de) | 1969-01-09 |
| DK120544C (da) | 1971-11-08 |
| SE335532B (de) | 1971-06-01 |
| NL6408066A (de) | 1965-01-18 |
| BE650445A (de) | 1965-01-11 |
| DE1445835B2 (de) | 1976-04-22 |
| CS166185B2 (de) | 1976-01-29 |
| BE650444A (de) | 1965-01-11 |
| FR1455030A (fr) | 1966-04-01 |
| DK124334B (da) | 1972-10-09 |
| CH469739A (de) | 1969-03-15 |
| DK120544B (de) | 1971-06-14 |
| NL6408067A (de) | 1965-01-18 |
| US3243435A (en) | 1966-03-29 |
| IL21639A (en) | 1968-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH436339A (de) | Verfahren zur Herstellung basischer Dibenzooxepin- bzw. Dibenzothiepin-Derivate | |
| CH556865A (de) | Verfahren zur herstellung von azolyl-furanderivaten. | |
| CH431540A (de) | Verfahren zur Herstellung von Oxadiazol-Derivaten | |
| CH433309A (de) | Verfahren zur Herstellung von Derivaten des 7-Oxy-2-oxo-1,2-dihydrochinolins | |
| CH469022A (de) | Verfahren zur Herstellung von Derivaten des Cephalosporin C | |
| CH451153A (de) | Verfahren zur Herstellung von 3-Hydroxyisoxazolderivaten | |
| CH459196A (de) | Verfahren zur Herstellung von 4,6-Pregnadienderivaten | |
| CH441308A (de) | Verfahren zur Herstellung von Hydrazonderivaten | |
| CH460783A (de) | Verfahren zur Herstellung von Derivaten des 3-Phenylpyrrols | |
| CH417604A (de) | Verfahren zur Herstellung von Benzamidobenzanilid-Derivaten | |
| CH448119A (de) | Verfahren zur Herstellung von Triarylalkanderivaten | |
| CH443297A (de) | Verfahren zur Herstellung von Oxazolidinderivaten | |
| CH494731A (de) | Verfahren zur Herstellung von Derivaten von Dibenzocyclo-heptenen | |
| CH449610A (de) | Verfahren zur Herstellung von Oestra-4,9-dien-3-olen | |
| CH462826A (de) | Verfahren zur Herstellung von Aminoacylcytosaminderivaten | |
| CH442309A (de) | Verfahren zur Herstellung von Derivaten von Cephalosporin C. | |
| CH444163A (de) | Verfahren zur Herstellung von Derivaten des Cephalosporin C | |
| CH449017A (de) | Verfahren zur Herstellung von Derivaten des 3-Phenylpyrrols | |
| CH484855A (de) | Verfahren zur Herstellung von Acryloylphenolderivaten | |
| CH436342A (de) | Verfahren zur Herstellung von substituierten 1-Hydroxy-2-amino-1-phenylalkanen | |
| CH445473A (de) | Verfahren zur Herstellung von Iminocycloheptatrienderivaten | |
| CH471817A (de) | Verfahren zur Herstellung von Derivaten des Cephalosporin C | |
| CH435297A (de) | Verfahren zur Herstellung von 4-Aminoantipyrinderivaten | |
| CH453543A (de) | Verfahren zur Herstellung von Hydrazinderivaten | |
| CH444165A (de) | Verfahren zur Herstellung von Piperazinderivaten |